Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Chronic Pain × Ketorolac × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain, Postoperative 1 Pain 1 Multiple Myeloma 1 Lymphoma, Follicular 1 Lymphoma 1 Inflammation 1 Curative Breast Cancer Surgery 1 Chronic Pain 1 Carcinoma, Renal Cell 1 Breast Neoplasms 1 Agnosia 1 Acute Pain 1

Interventions

Sodium Chloride 2 Tapentadol 1 Ropivacaine 1 Pregabalin 1 Meloxicam 1 Lidocaine 1 Ketorolac Tromethamine 1 Ketorolac 1 Ketamine 1 Fentanyl 1 Educational Status 1 Anti-Inflammatory Agents, Non-Steroidal 1 6'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01789216 2021-02-03

PAIN

Major Extremity Trauma Research Consortium

Phase 3 Completed

Lymphoma, Follicular, Chronic Pain, Acute Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡